Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Accuray Incorporated (ARAY)

Accuray Incorporated (ARAY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 300,350
  • Shares Outstanding, K 90,467
  • Annual Sales, $ 418,790 K
  • Annual Income, $ -16,430 K
  • 60-Month Beta 1.96
  • Price/Sales 0.73
  • Price/Cash Flow N/A
  • Price/Book 5.36

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.02
  • Number of Estimates 3
  • High Estimate 0.00
  • Low Estimate -0.05
  • Prior Year -0.01
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.31 +0.30%
on 02/21/20
4.68 -29.06%
on 01/29/20
-0.34 (-9.29%)
since 01/21/20
3-Month
2.59 +28.19%
on 01/10/20
4.68 -29.06%
on 01/29/20
+0.56 (+20.29%)
since 11/21/19
52-Week
2.35 +41.28%
on 08/16/19
5.40 -38.52%
on 02/22/19
-1.95 (-37.00%)
since 02/21/19

Most Recent Stories

More News
Fresenius Medical (FMS) Q4 Earnings Beat Estimates, Up Y/Y

Fresenius Medical's (FMS) fourth-quarter earnings benefit from strong segmental performance and solid 2020 EPS outlook.

SYK : 224.30 (-0.08%)
ARAY : 3.32 (-1.48%)
FMS : 41.01 (-2.40%)
IDXX : 278.11 (-1.19%)
Integer Holdings (ITGR) Q4 Earnings & Revenues Top Estimates

Integer Holdings' (ITGR) fourth-quarter earnings benefit from higher revenues and strong segmental performance.

SYK : 224.30 (-0.08%)
ARAY : 3.32 (-1.48%)
IDXX : 278.11 (-1.19%)
ITGR : 97.85 (-1.09%)
Masimo (MASI) Q4 Earnings Beat Estimates, View Impressive

Masimo (MASI) sees expansion in gross and operating margin in Q4.

SYK : 224.30 (-0.08%)
ARAY : 3.32 (-1.48%)
MASI : 178.37 (-1.89%)
IDXX : 278.11 (-1.19%)
Syneos Health (SYNH) Tops Q4 Earnings and Revenue Estimates

We are upbeat about the strong year-over-year revenue growth in the Clinical Solutions segment of Syneos Health (SYNH) in Q4.

SYK : 224.30 (-0.08%)
ARAY : 3.32 (-1.48%)
ABC : 97.00 (+0.49%)
SYNH : 70.82 (-0.95%)
Henry Schein (HSIC) Q4 Earnings and Revenues Top Estimates

Henry Schein (HSIC) registers solid performance by each of its key operating businesses in Q4.

SYK : 224.30 (-0.08%)
ARAY : 3.32 (-1.48%)
HSIC : 67.54 (-2.00%)
BC : 63.71 (-3.12%)
The Zacks Analyst Blog Highlights: Smith Micro Software, Accuray, Vista Outdoor, Synaptics and CareDx

The Zacks Analyst Blog Highlights: Smith Micro Software, Accuray, Vista Outdoor, Synaptics and CareDx

ARAY : 3.32 (-1.48%)
SMSI : 5.83 (-2.02%)
SYNA : 76.16 (-2.06%)
VSTO : 9.38 (-0.21%)
CDNA : 28.25 (+0.18%)
Amedisys (AMED) Q4 Earnings Beat Estimates, Revenues Miss

Amedisys' (AMED) fourth-quarter earnings benefit from solid year-over-year growth in Medicare and non-Medicare revenues within Home Health.

SYK : 224.30 (-0.08%)
AMED : 194.03 (-0.05%)
ARAY : 3.32 (-1.48%)
IDXX : 278.11 (-1.19%)
Ecolab (ECL) Earnings and Revenues Miss Estimates in Q4

Strength in the Global Industrial arm drives Ecolab's (ECL) Q4 results.

ECL : 207.50 (+0.58%)
SYK : 224.30 (-0.08%)
ARAY : 3.32 (-1.48%)
IDXX : 278.11 (-1.19%)
Medtronic (MDT) Q3 Earnings Top Estimates, Revenues Miss

Medtronic (MDT) demonstrates better-than-expected Q3 performances at CER, backed by growth in all major business segments and geographies.

MDT : 113.28 (-0.51%)
SYK : 224.30 (-0.08%)
ARAY : 3.32 (-1.48%)
ABC : 97.00 (+0.49%)
Trump Mulling Tax Cuts to Incentivize Stock Buying? 6 Picks

President Trump's tenure has seen Wall Street perform exceptionally well so far. In fact, Trump often cites Wall Street's bull run as a reflection of his good governance.

ARAY : 3.32 (-1.48%)
OMI : 6.95 (-2.80%)
SMSI : 5.83 (-2.02%)
SYNA : 76.16 (-2.06%)
VSTO : 9.38 (-0.21%)
CDNA : 28.25 (+0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade ARAY with:

Business Summary

ACCURAY INCORPORATED based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends...

See More

Key Turning Points

2nd Resistance Point 3.42
1st Resistance Point 3.37
Last Price 3.32
1st Support Level 3.29
2nd Support Level 3.26

See More

52-Week High 5.40
Fibonacci 61.8% 4.23
Fibonacci 50% 3.88
Fibonacci 38.2% 3.52
Last Price 3.32
52-Week Low 2.35

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar